IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Dennis Gillings

IQVIA Holdings Inc.

AHRM is a specialty CRO that focuses on Health Economics and Outcomes Research. The company integrates and conducts clinical trials and outcomes research across various therapeutic areas.

Applied Healthcare Research Management Inc. (AHRM)

Evolve Clinical Research is a multi-site network that increases the availability of clinical trials by embedding research sites within physicians' offices.

Evolve Clinical Research

GBA Group is an international life science service provider that offers a range of analytical, logistical, and specialized services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water, and the environment. It provides laboratory analytics, data management, clinical trial logistics, and consulting for private companies and public institutions concerning their research, product development, market entry, and consumer protection activities.

Metric
Company Name	IQVIA Holdings Inc.	Applied Healthcare Research Management Inc. (AHRM)	Evolve Clinical Research	GBA Group
Symbol	IQV
MSH ID	COM:IQVIA	COM:AHRMINC	COM:EVOLVECLINICALRESEARCH	COM:GBA-GROUP
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Diagnostics & Research	Contract Research Organization (CRO)	Clinical Research	Life Sciences
Country	US	US	US	DE
Stage				Private Equity Round
Employee Count	87K
Website	iqvia.com	ahrminc.com	evolveclinicalresearch.com	gba-group.com
LinkedIn		applied-healthcare-resource-management		gbagroup
Founders

Metric
Market Cap	38.62B
Enterprise Value
Monthly Web Traffic		1	26.11K
Web Traffic Growth			2.31
Valuation
Raised Capital

Metric
Revenue	15.01B
Revenue (LTM)
Revenue (NTM)
Gross Profit	4.13B
EBITDA	3.21B
Operating Income	2.08B
Net Income	1.36B
EPS	7.39
Diluted EPS	7.29
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.33
Operating Profit Margin	0.14
EBITDA Margin	0.21
Net Profit Margin	0.09
Return on Equity	0.23
Return on Assets	0.05
Return on Capital Employed	0.11

COM:IQVIA

IQVIA Holdings, Inc.

Last Close

197.60

22/11 21:00

Market Cap

38.62B

Beta: -

Volume Today

1.87M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	34.55
P/B Ratio	6.64
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.06
EV Multiple	10.17

Metric
Days Sales Outstanding	80.49
Days Payables Outstanding	118.21
Days Inventory Outstanding
Operating Cycle	93.44
Cash Conversion Cycle	93.44
Asset Turnover	0.58

Metric
Operating Cash Flow	2.15B
Free Cash Flow	1.50B
Cash Flow to Debt	0.18
Operating Cash Flow/Sales	0.16
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	1.38B
Accounts Receivable	-388M
Inventory
Goodwill	14.57B
Debt to Capitalization	0.69
Debt to Assets	0.53
Current Ratio	0.79
Quick Ratio	0.85

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue
SG&A to Revenue